• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

豚草霉素诱导 BRAFV600E 抑制的 FRO 间变性甲状腺癌细胞发生 Paraptosis。

Tunicamycin induces paraptosis potentiated by inhibition of BRAFV600E in FRO anaplastic thyroid carcinoma cells.

机构信息

Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Hallym University, Chuncheon, Republic of Korea.

Ilsong Institute of Life Science, Gyeonggi-Do, Republic of Korea.

出版信息

Anticancer Res. 2014 Sep;34(9):4857-68.

PMID:25202067
Abstract

BACKGROUND/AIM: The aim of the present study was to elucidate whether tunicamycin (TM) induces paraptosis as a cell death subroutine in anaplastic thyroid carcinoma (ATC) cells.

MATERIALS AND METHODS

8505C, CAL62 and FRO cells were used. After treatment of TM, cell survival and morphology were investigated. The effect of the BRAF(V600E) inhibitor PLX4032 in combination with TM was evaluated.

RESULTS

In FRO cells, TM induced paraptosis characteristic of cytoplasmic vacuolation and endoplasmic reticulum (ER) swelling, which was not associated with caspase activation and ER stress. TM-induced paraptosis was ameliorated by pre-treatment with the translation inhibitor cycloheximide, while it was accelerated by pre-treatment with the proteasome inhibitor MG132. PLX4032 augmented TM-induced paraptosis.

CONCLUSION

TM induces paraptosis relevant to de novo protein synthesis and proteasomal activity, and inhibition of BRAF(V600E) potentiates TM-induced paraptosis in FRO cells harboring BRAF(V600E).

摘要

背景/目的:本研究旨在阐明衣霉素(TM)是否通过凋亡小体程序诱导甲状腺未分化癌(ATC)细胞死亡。

材料和方法

使用 8505C、CAL62 和 FRO 细胞。用 TM 处理后,观察细胞存活和形态。评估 BRAF(V600E)抑制剂 PLX4032 与 TM 的联合作用。

结果

在 FRO 细胞中,TM 诱导具有细胞质空泡化和内质网(ER)肿胀特征的凋亡小体,这与半胱天冬酶激活和 ER 应激无关。用翻译抑制剂环己酰亚胺预处理可减轻 TM 诱导的凋亡小体,而用蛋白酶体抑制剂 MG132 预处理可加速 TM 诱导的凋亡小体。PLX4032 增强了 TM 诱导的 FRO 细胞中 BRAF(V600E) 存在的凋亡小体。

结论

TM 诱导与从头蛋白质合成和蛋白酶体活性相关的凋亡小体,抑制 BRAF(V600E) 增强了 FRO 细胞中 TM 诱导的凋亡小体。

相似文献

1
Tunicamycin induces paraptosis potentiated by inhibition of BRAFV600E in FRO anaplastic thyroid carcinoma cells.豚草霉素诱导 BRAFV600E 抑制的 FRO 间变性甲状腺癌细胞发生 Paraptosis。
Anticancer Res. 2014 Sep;34(9):4857-68.
2
Inhibition of p21 and Akt potentiates SU6656-induced caspase-independent cell death in FRO anaplastic thyroid carcinoma cells.抑制 p21 和 Akt 可增强 SU6656 诱导的 FRO 间变性甲状腺癌细胞中的 caspase 非依赖性细胞死亡。
Horm Metab Res. 2013 Jun;45(6):408-14. doi: 10.1055/s-0033-1333716. Epub 2013 Feb 5.
3
The hsp70 inhibitor VER155008 induces paraptosis requiring de novo protein synthesis in anaplastic thyroid carcinoma cells.热休克蛋白70(Hsp70)抑制剂VER155008可诱导间变性甲状腺癌细胞发生副凋亡,此过程需要从头合成蛋白质。
Biochem Biophys Res Commun. 2014 Nov 7;454(1):36-41. doi: 10.1016/j.bbrc.2014.10.060. Epub 2014 Oct 18.
4
Akt inhibition enhances the cytotoxic effect of apigenin in combination with PLX4032 in anaplastic thyroid carcinoma cells harboring BRAFV600E.Akt 抑制增强了芹菜素联合 PLX4032 在携带 BRAFV600E 的间变性甲状腺癌细胞中的细胞毒性作用。
J Endocrinol Invest. 2013 Dec;36(11):1099-104. doi: 10.3275/9099. Epub 2013 Sep 27.
5
Cytostatic activity of adenosine triphosphate-competitive kinase inhibitors in BRAF mutant thyroid carcinoma cells.三磷酸腺苷竞争型激酶抑制剂在 BRAF 突变型甲状腺癌细胞中的细胞抑制活性。
J Clin Endocrinol Metab. 2010 Jan;95(1):450-5. doi: 10.1210/jc.2009-0373. Epub 2009 Oct 30.
6
BAG3 down-modulation reduces anaplastic thyroid tumor growth by enhancing proteasome-mediated degradation of BRAF protein.下调 BAG3 表达通过增强蛋白酶体介导的 BRAF 蛋白降解抑制间变性甲状腺肿瘤生长。
J Clin Endocrinol Metab. 2012 Jan;97(1):E115-20. doi: 10.1210/jc.2011-0484. Epub 2011 Nov 9.
7
S100A4 Knockout Sensitizes Anaplastic Thyroid Carcinoma Cells Harboring BRAFV600E/Mt to Vemurafenib.S100A4基因敲除使携带BRAFV600E/Mt的间变性甲状腺癌细胞对维莫非尼敏感。
Cell Physiol Biochem. 2018;49(3):1143-1162. doi: 10.1159/000493296. Epub 2018 Sep 7.
8
Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status.索拉非尼抑制甲状腺癌细胞内的信号通路,诱导细胞周期停滞和细胞死亡,无论其组织学来源或BRAF突变状态如何。
BMC Cancer. 2015 Mar 26;15:184. doi: 10.1186/s12885-015-1186-0.
9
Targeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclinical models of human thyroid cancer.PLX4720 通过靶向 BRAFV600E 在人类甲状腺癌的临床前模型中显示出强大的抗迁移和抗侵袭活性。
Oncologist. 2011;16(3):296-309. doi: 10.1634/theoncologist.2010-0317. Epub 2011 Feb 25.
10
Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer.在具有免疫活性的间变性甲状腺癌小鼠模型中,联合使用BRAF抑制剂和抗PD-L1抗体可显著提高肿瘤消退和抗肿瘤免疫力。
Oncotarget. 2016 Mar 29;7(13):17194-211. doi: 10.18632/oncotarget.7839.

引用本文的文献

1
Potent Inducers of Paraptosis through Electronic Tuning of Hemicyanine Electrophiles.通过半菁亲电试剂的电子调谐实现副凋亡的强效诱导剂。
J Am Chem Soc. 2025 Sep 10;147(36):32571-32579. doi: 10.1021/jacs.5c07109. Epub 2025 Aug 25.
2
Transient receptor potential vanilloid channel 2 contributes to multi-modal endoplasmic reticulum and perinuclear space dilations that can also be observed in prion-infected mice.瞬时受体电位香草酸亚型通道2会导致多模式内质网和核周间隙扩张,这种扩张在朊病毒感染的小鼠中也能观察到。
Acta Neuropathol. 2025 Jun 23;149(1):68. doi: 10.1007/s00401-025-02906-2.
3
Anaplastic thyroid cancer: Genetic roles, targeted therapy, and immunotherapy.
间变性甲状腺癌:基因作用、靶向治疗及免疫治疗
Genes Dis. 2024 Aug 30;12(4):101403. doi: 10.1016/j.gendis.2024.101403. eCollection 2025 Jul.
4
A unified model for the origins of spongiform degeneration and other neuropathological features in prion diseases.朊病毒疾病中海绵状变性及其他神经病理学特征起源的统一模型。
ArXiv. 2025 Jan 15:arXiv:2412.16678v2.
5
Mitochondrial calcium overload contributes to cannabinoid-induced paraptosis in hormone-responsive breast cancer cells.线粒体钙超载导致激素反应性乳腺癌细胞中大麻素诱导的 Paraptosis。
Cell Prolif. 2024 Oct;57(10):e13650. doi: 10.1111/cpr.13650. Epub 2024 May 9.
6
Targeting paraptosis in cancer: opportunities and challenges.靶向癌症中的副凋亡:机遇与挑战。
Cancer Gene Ther. 2024 Mar;31(3):349-363. doi: 10.1038/s41417-023-00722-y. Epub 2024 Jan 4.
7
Paraptosis: a unique cell death mode for targeting cancer.副凋亡:一种针对癌症的独特细胞死亡模式。
Front Pharmacol. 2023 Jun 15;14:1159409. doi: 10.3389/fphar.2023.1159409. eCollection 2023.
8
Tunicamycin as a Novel Redifferentiation Agent in Radioiodine Therapy for Anaplastic Thyroid Cancer.他霉素作为一种新型分化诱导剂在放射性碘治疗间变性甲状腺癌中的应用。
Int J Mol Sci. 2021 Jan 22;22(3):1077. doi: 10.3390/ijms22031077.
9
MEG-3-mediated Wnt/β-catenin signaling pathway controls the inhibition of tunicamycin-mediated viability in glioblastoma.MEG-3介导的Wnt/β-连环蛋白信号通路调控胶质母细胞瘤中衣霉素介导的细胞活力抑制作用。
Oncol Lett. 2018 Sep;16(3):2797-2804. doi: 10.3892/ol.2018.9048. Epub 2018 Jun 28.
10
Tunicamycin inhibits progression of glioma cells through downregulation of the MEG-3-regulated wnt/β-catenin signaling pathway.衣霉素通过下调MEG-3调节的Wnt/β-连环蛋白信号通路来抑制胶质瘤细胞的进展。
Oncol Lett. 2018 Jun;15(6):8470-8476. doi: 10.3892/ol.2018.8416. Epub 2018 Apr 3.